Literature DB >> 14505919

Safety and efficacy of CpG-containing oligodeoxynucleotides as immunological adjuvants in rabbits.

X P Ioannou1, S M Gomis, R Hecker, L A Babiuk, S van Drunen Littel-van den Hurk.   

Abstract

The efficacy of oligodeoxynucleotides containing unmethylated CpG dinucleotides (CpG ODN) as an adjuvant for rabbits was assessed alone and in combination with aluminum hydroxide (CpG/alum). The CpG/alum combination elicited a greater immune response to several antigens compared to Freund's adjuvant. A non-CpG/alum combination did not have the same effects as CpG/alum suggesting that the adjuvanticity was related to the CpG motifs. In addition, we formulated one of the antigens with combinations of CpG ODN and 30 or 10% Emulsigen (Em) [CpG/Em (30%) and CpG/Em (10%)]. Both CpG/Em (30%) and CpG/Em (10%) were more effective than Em, and equivalent to CpG/alum. The CpG/Em (10%) combination caused minimal tissue damage. Our results demonstrate that the addition of CpG ODN to aluminum hydroxide or to 10% Em significantly improves the efficiency of these adjuvants, without enhancing tissue reaction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14505919     DOI: 10.1016/s0264-410x(03)00437-7

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  Epitope-focused peptide immunogens in human use adjuvants protect rabbits from experimental inhalation anthrax.

Authors:  Jon Oscherwitz; Daniel Feldman; Fen Yu; Kemp B Cease
Journal:  Vaccine       Date:  2014-11-30       Impact factor: 3.641

2.  Effect of a DNA-based immunostimulant on growth, performance, and expression of inflammatory and immune mediators in beef calves abruptly weaned and introduced to a complete ration.

Authors:  Amelia R Woolums; Brandi B Karisch; Jane A Parish; Jooyoun Park; Keun Seok Seo; Peres Badial; Steven C Olsen
Journal:  J Anim Sci       Date:  2019-01-01       Impact factor: 3.159

3.  Combination of CpG Oligodeoxynucleotide and Anti-4-1BB Antibody in the Treatment of Multiple Hepatocellular Carcinoma in Mice.

Authors:  Shizhao Ma; Xinying Yang; Huifang Zhou; Chaoqun Zhang; Jiwen Kang; Dianxing Sun
Journal:  Onco Targets Ther       Date:  2020-07-20       Impact factor: 4.147

4.  Evaluation of recombinant Onchocerca volvulus activation associated protein-1 (ASP-1) as a potent Th1-biased adjuvant with a panel of protein or peptide-based antigens and commercial inactivated vaccines.

Authors:  Wenjun Xiao; Lanying Du; Chao Liang; Jie Guan; Shibo Jiang; Sara Lustigman; Yuxian He; Yusen Zhou
Journal:  Vaccine       Date:  2008-08-19       Impact factor: 3.641

5.  Materials that harness and modulate the immune system.

Authors:  Jamal S Lewis; Krishnendu Roy; Benjamin G Keselowsky
Journal:  MRS Bull       Date:  2014-01-01       Impact factor: 6.578

6.  M cell-targeted ocular immunization: effect on immunoglobulins in tears, feces, and serum.

Authors:  Thomas E Phillips; Jeremy Sharp; Kay Rodgers; Hongshan Liu
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-11-05       Impact factor: 4.799

7.  Adjuvants for Leishmania vaccines: from models to clinical application.

Authors:  Vanitha S Raman; Malcolm S Duthie; Christopher B Fox; Greg Matlashewski; Steven G Reed
Journal:  Front Immunol       Date:  2012-06-11       Impact factor: 7.561

8.  The effect of TLR9 agonist CpG oligodeoxynucleotides on the intestinal immune response of cobia (Rachycentron canadum).

Authors:  Omkar Byadgi; Dinda Puteri; Jai-Wei Lee; Tsung-Chou Chang; Yan-Horn Lee; Chun-Yen Chu; Ta-Chih Cheng
Journal:  J Immunol Res       Date:  2014-06-02       Impact factor: 4.818

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.